Exclusive paternal origin of new mutations in Apert syndrome

Apert syndrome results from one or other of two specific nucleotide substitutions, both CG transversions, in the fibroblast growth factor receptor 2 (FGFR2) gene. The frequency of new mutations, estimated as 1 per 65,000 live births, implies germline transversion rates at these two positions are currently the highest known in the human genome. Using a novel application of the amplification refractory mutation system (ARMS), we have determined the parental origin of the new mutation in 57 Apert families: in every case, the mutation arose from the father. This identifies the biological basis of the paternal age effect for new mutations previously suggested for this disorder.

1. Blank, C.E. Apert's syndrome (a type of acrocephalosyndactyly) — observations on a British series of thirty-nine cases. Ann. Hum. Genet. 24, 151−164 (1960).
2. Upton, J. & Zuker, R.M. Apert syndrome. Clin. Plast. Surg. 18, 1−435 (1991).
3. Slaney, S.F. et al. Differential effects of FGFR2 mutations on syndactyly and cleft palate in Apert syndrome. Am. J. Hum. Genet. 58, 923−932 (1996).
4. Cohen, M.M., et al. Birth prevalence study of the Apert syndrome. Am. J. Med. Genet. 42, 655−659 (1992).
5. Erickson, J.D. & Cohen, M.M.Jr. A study of parental age effects on the occurrence of fresh mutations for the Apert syndrome. Ann. Hum. Genet. 38, 89−96 (1974).
6. Lenz, W., Abhängigkeit der Mutationen vom Alter des Vaters. in Klinische Genetik in der Pädiatrie 2. Symposion in Mainz (eds. Spranger J. & olksdorf, M.) 125−136 (Stuttgart, Georg Thieme Vertag, 1980).
7. Risch, N., Reich, E.W., Wishnick, M.M. & McCarthy, J.G. Spontaneous mutation and parental age in humans. Am. J. Hum. Genet. 41, 218−248 (1987).
8. Vogel, F. & Motulsky, A.G., Human Genetics. Problems and Approaches (Springer-Verlag, Berlin, Heidelberg, 1986).
9. Wilkie, A.O.M. et al. Apert syndrome results from localized mutations of GFR2 and is allelic with Crouzon syndrome. Nature Genet. 9, 165−172 (1995).
10. Park, W.-J. et al. Analysis of phenotypic features and FGFR2 mutations in Apert syndrome. Am. J. Hum. Genet. 57, 321−328 (1995).
11. Meyers, G.A. et al. FGFR2 exon IIIa and IIIc mutations in Crouzon, Jackson-Weiss, and Pfeiffer syndromes: evidence for missense changes, insertions, and a deletion due to alternative splicing. Am. J. Hum. Genet. 58, 491−498 (1996).
12. Sommer, S.S. Recent human germ-line mutation: inferences from patients with hemophilia B. Trends Genet. 11, 141−147 (1995).
13. Stamatoyannopoulos, G. & Nute, P.E. De novo mutations producing unstable Hbs or Hbs M. Hum. Genet. 60, 181−188 (1982).
14. Neel, J.V. et al. The rate with which spontaneous mutation alters the electrophoretic mobility of polypeptides. Proc. Natl. Acad. Sci. USA. 83, 389−393 (1986).
15. Wilkie, A.O.M., Morriss-Kay, G.M., Jones, E.Y. & Heath, J.K. Functions of fibroblast growth factors and their receptors. Curr. Biol. 5, 500−507 (1995).
16. Muenke, M. & Schell, U. Fibroblast-growth-factor receptor mutations in human skeletal disorders. Trends Genet. 11, 308−313 (1995).
17. Muenke, M. et al. A common mutation in the fibroblast growth factor receptor 1 gene in Pfeiffer syndrome. Nature Genet. 8, 269−274 (1994).
18. Carlson, K.M. et al. Parent-of-origin effects in multiple endocrine neoplasia Type 2B. Am. J. Hum. Genet. 55, 1076−1082 (1994).
19. Wilson, L.C., Oude Luttikhuis, M.E.M., Clayton, P.T., Fraser, W.D. & Trembath, R.C. Parental origin of GS gene mutations in Albright's hereditary osteodystrophy. J. Med. Genet. 31, 835−839 (1994).
20. Kitamura, Y., Scavarda, N., Wells, S.A.Jr. Jackson, C.E. & Goodfellow, R.J. Two maternally derived missense mutations in the tyrosine kinase domain of the RET protooncogene in a patient with de novo MEN 2B. Hum. Mol. Genet. 4, 1987−1988 (1995).
21. Newton, C.R. et al. Analysis of any point mutation in DNA. The amplification refractory mutation system (ARMS). Nucl. Acids Res. 17, 2503−2516 (1989).
22. Kwok, S. et al. Effects of primer-template mismatches on the polymerase chain reaction: Human immunodeficiency virus type 1 model studies. Nucl. Acids Res. 18, 999−1005 (1990).
23. Shiang, R. et al. Mutations in the transmembrane domain of FGFR3 cause the most common genetic form of dwarfism, achondroplasia. Cell. 78, 335−342 (1994).
24. Rousseau, F. et al. Mutations in the gene encoding fibroblast growth factor receptor-3 in achondroplasia. Nature. 371, 252−254 (1994).
25. Bellus, G.A. et al. Achondroplasia is defined by recurrent G380R mutations of FGFR3. Am. J. Hum. Genet. 56, 368−373 (1995).
26. Penrose, L.S. Parental age and mutation. Lancet. 2, 312−313 (1955).
27. Orioli, I.M., Castilla, E.E., Scarano, G. & Mastroiacovo, P. Effect of paternal age in achondroplasia, thanatophoric dysplasia, and osteogenesis imperfecta. Am. J. Med. Genet. 59, 209−217 (1995).
28. Reiser, C.A., Pauli, R.M. & Hall, J.G. Achondroplasia: unexpected familial recurrence. Am. J. Med. Genet. 19, 245−250 (1984).
29. Dodinval, P. & Le Marec, B. Genetic counselling in unexpected familial recurrence of achondroplasia. Am. J. Med. Genet. 28, 949−954 (1987).
30. Meyers, G.A., Ortow, S.J., Munro, I.R., Przylepa, K.A. & Jabs, E.W. Fibroblast growth factor receptor 3 (FGFR3) transmembrane mutation in Crouzon syndrome with acanthosis nigricans. Nature Genet. 9, 462−464 (1995).
31. Chandley, A.C. On the parental origin of de novo mutation in man. J. Med. Genet. 28, 217−223 (1991).
32. White, P.C., Tusi-Luna, M.-T., New, M.I. & Speiser, R.W. Mutations in steroid 21 -hydroxylase (CYP21). Hum. Mutat. 3, 373−378 (1994).
33. Wolfe, K.H., Sharp, P.M. & Li, W.-H. Mutation rates differ among regions of the mammalian genome. Nature 337, 283−285 (1989).
34. Cooper, D.N. & Krawczak, M., Human Gene Mutation(BIOS Scientific Publishers Ltd. , Oxford, 1993).
35. Driscoll, D.J. & Migeon, B.R. Sex difference in methylation of single-copy genes in human meiotic germ cells: implications for X chromosome inactivation, parental imprinting and origin of CpG mutations. Somatic. Cell Mol. Genet. 16, 267−282 (1990).
36. Lichtenauer-Kaligis, E.G.R. et al. Genomic position influences spontaneous mutagenesis of an integrated retroviral vector containing the hprt cDNA as target for mutagenesis. Hum. Mol. Genet. 2, 173−182 (1993).
37. Ketterling, R.R., Vielhaber, E. & Sommer, S.S. The rates of G:CT:A and G:CC:G transversions at CpG dinucleotides in the human factor IX gene. Am. J. Hum. Genet. 54, 831−835 (1994).
38. Müller, B. et al. Estimation of the male and female mutation rates in Duchenne muscular dystrophy (DMD). Hum. Genet. 89, 204−206 (1992).
39. Ketterling, R.R. et al. Germ-line origins of mutation in families with hemophilia B: the sex ratio varies with the type of mutation. Am. J. Hum. Genet. 52, 152−166 (1993).
40. Richards, F.M. et al. Molecular analysis of de novo germline mutations in the von Hippel-Lindau disease gene. Hum. Mol. Genet. 4, 2139−2143 (1995).
41. Grimm, T. et al. On the origin of deletions and point mutations in Duchenne muscular dystrophy: most deletions arise in oogenesis and most point mutations result from events in spermatogenesis. J. Med. Genet. 31, 183−186 (1994).
42. Dryja, T.R. et al. Parental origin of mutations of the retinoblastoma gene. Nature. 339, 556−558 (1989).
43. Jadayel, D. et al. Paternal origin of new mutations in Von Recklinghausen neurofibromatosis. Nature 343, 558−559 (1990).
44. Stephens, K. et al. Preferential mutation of the neurofibromatosis type 1 gene in paternally derived chromosomes. Hum. Genet. 88, 279−282 (1992).
45. Rossiter, J.R. et al. Factor VIII gene inversions causing severe hemophilia A originate almost exclusively in male germ cells. Hum. Mol. Genet. 3, 1035−1039 (1994).
46. Antonarakis, S.E. et al. Factor VIII gene inversions in severe hemophilia A: results of an international consortium study. Blood. 96, 2206−2212 (1995).
47. li, S., Sobell, J.L., & Sommer, S.S., From molecular variant to disease: initial steps in evaluating the association of transthyretin M119 with disease. Am. J. Hum. Genet. 50, 29−41 (1992).
48. Allanson, J.E. Germinal mosaicism in Apert syndrome. Clin. Genet. 29, 429−433 (1986).
49. Byers, P.H., Wallis, G.A., & Willing, M.C., Osteogenesis imperfecta: translation of mutation to phenotype. J. Med. Genet. 28, 433−442 (1991).
50. Office of Population Censuses and Surveys. Registrar General's statistical review of England and Wales. Part II, Tables, population. (HMSO, London, 1964−1973).
51. Office of Population Censuses and Surveys. Birth statistics, series FM1. HMSO, London, 1974−1993.
52. Gyapay, G. et al. The 1993−94 Généthon human genetic linkage map. Nature Genet. 7, 246−339 (1994).
53. Bailey, D.M.D., Affara, N.A. & Ferguson-Smith, M.A. The X-Y homologous gene amelogenin maps to the short arms of both the X and Y chromosomes and is highly conserved in primates. Genomics 14, 203−205 (1992).
54. Miki, T. et al. Determination of ligand-binding specificity by alternative splicing: two distinct growth factor receptors encoded by a single gene. Proc. Natl. Acad. Sci. USA 89, 246−250 (1992).
55. Thein, S.L. & Hinton, J. A simple and rapid method of direct sequencing using Dynabeads. Br. J. Haemal. 79, 113−115 (1991).

	Top

	Top